Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management Patterns of AntiThrombotics and Outcomes in Patients With Hematological Malignancy and ThrombocytopEnia: a Prospective Registry (MATTER Study)

NCT03288441 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03288441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03288441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management Patterns of AntiThrombotics and Outcomes in Patients With Hematological Malignancy and ThrombocytopEnia: a Prospective Registry (MATTER Study)
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 20, 2018
Completion date
December 31, 2021
Enrollment
300 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, hematologic neoplasms, platelet aggregation inhibitors, thrombocytopenia